Linked Life Data

1778787

Source:http://linkedlifedata.com/resource/pubmed/id/1778787

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1992-3-11
pubmed:abstractText
The structures of novel endothelin-binding inhibitors, BE-18257A and BE-18257B, were elucidated by spectral analyses and chemical studies. Both inhibitors were found to have a cyclic pentapeptide structure containing three D-form amino acid residues, namely, the structures of BE-18257A and BE-18257B were elucidated to be cyclo(-D-Glu-L-Ala-D-Val-L-Leu-D-Trp-) and cyclo(-D-Glu-L-Ala-allo-D-Ile-L-Leu-D-Trp-), respectively.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-8820
pubmed:author
pubmed:issnType
Print
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1348-56
pubmed:dateRevised
2001-11-28
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Endothelin-binding inhibitors, BE-18257A and BE-18257B II. Structure determination.
pubmed:affiliation
Central Research, Banyu Pharmaceutical Co., Ltd., Tokyo, Japan.
pubmed:publicationType
Journal Article